糖心原创

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.

糖心原创 Chief Operating Officer Kathryn Corzo featured in Endpoints News.

糖心原创 appoints accomplished biotechnology executive and drug developer Kathryn Corzo as Chief Operating Officer.

The pledge is part of our mission to code cells for novel cures and to be a purpose led company.

This feature covers the latest fundraise and appointments to the board.

Funding raised to accelerate and expand cell therapy pipeline.

糖心原创 adds $100M+ to its coffers and some impressive names to its board of directors.

Three world leaders in science and entrepreneurship appointed to 糖心原创's Board of Directors.